GetTopicDetailResponse(id=e518125411c7, topicName=腫瘤特異性, introduction=, content=腫瘤特異性 抗原克隆性, image=null, comments=0, allHits=180, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Mar 24 23:11:57 CST 2025, time=2025-03-24, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=502842, tagList=[TagDto(tagId=502842, tagName=腫瘤特異性)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2272170, encodeId=b6f722e2170f3, content=<a href='/topic/show?id=42a7523823' target=_blank style='color:#2F92EE;'>#CRISPR基因編輯#</a> <a href='/topic/show?id=e518125411c7' target=_blank style='color:#2F92EE;'>#腫瘤特異性#</a>, objectTitle=Nature：實體瘤治療的里程碑！基因魔改：為“抗癌神藥”CAR-T細胞裝上“腫瘤GPS”，實現(xiàn)定點爆破！, objectType=article, longId=885460, objectId=f2ae8854605b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230321/1679467455498_4754896.jpeg, objectUrl=/article/show_article.do?id=f2ae8854605b, replyNumber=0, likeNumber=26, createdTime=2025-07-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f2ae8854605b, moduleTitle=Nature：實體瘤治療的里程碑！基因魔改：為“抗癌神藥”CAR-T細胞裝上“腫瘤GPS”，實現(xiàn)定點爆破！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f2ae8854605b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2257571, encodeId=30b4225e571e4, content=<a href='/topic/show?id=e518125411c7' target=_blank style='color:#2F92EE;'>#腫瘤特異性#</a> <a href='/topic/show?id=7d67125412db' target=_blank style='color:#2F92EE;'>#抗原克隆性#</a>, objectTitle=腫瘤抗原的四大核心特性, objectType=article, longId=868378, objectId=91368683e826, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing.jpg, objectUrl=/article/show_article.do?id=91368683e826, replyNumber=0, likeNumber=37, createdTime=2025-03-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=91368683e826, moduleTitle=腫瘤抗原的四大核心特性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=91368683e826)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-03-24發(fā)表于陜西省
